Impact of Magnetic Resonance and Biomarkers for Screening for Prostate Cancer. Cost-effectiveness Analysis

Clinical trial NCT04283032 · UNKNOWN

Trial details

NCT number: NCT04283032
Sponsor: InvestigatorUrologyIBSAL
Status: UNKNOWN
Study type: OBSERVATIONAL

Establish the Efficacy Between the Four Schemes in Terms of the Aggressiveness of the Tumors According to the Gleason Classification Establish the Efficacy Between the Four Schemes in Terms of Morbidity Associated With the Technique Establish the Efficacy Between the Four Schemes in Terms of the Patient's Subjective Perception Regarding Pain and Quality of Life Establish the Association of the Tumor Biomarker in the Early Detection and Aggressiveness of Tumors Establish the Possible Interaction Between Biomarkers and Resonance in Different Prostate Biopsy Models to Define Tumor Presence and / or Tumor Aggressiveness Establish the Possible Relationship Between the Expression Profiles of the microRNAs Establish if There Are Differences Between Transrectal and Transperineal Prostatic Biopsy Schemes in Both Cases With and Without MRI

Start date: 2020-03-01
Primary completion: 2020-06-30
Enrollment: 628

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.